Abstract Kim et al., 2010). Our studies have focused on the development of antiarrhythmic drug, and we previously reported that papaverine (Choe et al., 2003), oxypeucedanin (Eun et al., 2005b), psoralen and their derivatives (Eun at al., 2005a; Eun et al., 2007) and torilin (Kwak et al., 2006) inhibited the hKv1.5 current. The present study was examined to investigate the effect of decursin from A. gigas on hKv1.5 channels using the whole-cell patch-clamp technique.
INTRODUCTION
Atrial fi brillation is the most frequent cardiac arrhythmia that can result in serious morbidity (Chung et al., 2001) . It is well known that various K + channels regulate the action potential duration and K + channel genes are differentially expressed depending on the regions of the heart. The main Kv channel genes expressed in the human heart are the hKv1.4, hKv1.5, hKv4.3 and HERG genes. All these genes are highly expressed in both the atrium and ventricle, whereas the hKv1.5 gene is preferentially expressed in the human atrium. Furthermore, the electrophysiological and pharmacological characteristics of the current generated by hKv1.5 channels is similar to the ultra-rapid delayed rectifi er K + current (I KUR ) recorded in human atrial myocytes (Fedida et al., 1998) . Thus, the hKv1.5 channel is thought to be an unique target for atrial fi brillation. In the present study, we tested decursin from the roots of Angelica gigas Nakai (Umbelliferae) on K + currents expressed in Ltk − cells. A. gigas Nakai has been used as a traditional medicine for treatment of anemia, a sedative and tonic agent (Yook, 1990) . Earlier investigations on the chemical constituents of A. gigas mainly dealt with the isolation of coumarins (Ryu et al., 1990; Jung et al., 1991; Pachaly et al., 1996; Lee et al., 2002) . The literature survey revealed that several pharmacological works, anti-tumor, inhibition of hepatic microsomal drug metabolizing enzyme, and inhibition of acetylcholinesterase activities, have been carried out on A. gigas (Shin et al., 1996; Kang et al., 2001; Lee et al., 2003; Lee et al., 2009;  Decursin was purifi ed from Angelica gigas Nakai, and its effects on the human Kv1.5 (hKv1.5) currents were recorded in mouse fi broblasts (Ltk − cells) by whole-cell patch-clamp technique. Decursin inhibited hKv1.5 current in a concentration-dependent manner, with an IC 50 value of 2.7 μM at +60 mV. Decursin accelerated the inactivation kinetics of the hKv1.5 channel, and slowed the deactivation kinetics of the hKv1.5 current, resulting in a tail crossover phenomenon. Also, decursin inhibited the hKv1.5 current in a use-dependent manner. These results strongly suggest that decursin is a kind of open-channel blocker of the hKv1.5 channel. 
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Extraction and isolation
The air-dried plant materials (300 g) were ground and extracted with MeOH under 50 o C. The resultant MeOH extract (52 g) followed by the successive solvent partition to give methylene chloride (20 g), n-BuOH (18 g) and H 2 O soluble fractions. Methylene chloride soluble fraction showed the most signifi cant hKv1.5 current inhibitory activity. This fraction was chromatographed over silica gel column using a solvent system n-hexnae-CH 2 Cl 2 -EtOAc (3:2:1) as an eluent to give three subfractions, Subfraction 2 was purifi ed by JAI-ODS column (MeOH) to give compound 1 (150 mg).
Compound 1 (Decursin, Fig. 1 
